Drug intelligence / Profile preview

Xin-Guan-1 formula

Development stage
Unknown
Lead developer
Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Xin-Guan-1 is a Traditional Chinese Medicine (TCM) herbal formula developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of COVID-19. It was investigated in observational clinical trials to evaluate its efficacy and safety when combined with standard of care in patients across the severity spectrum, including mild, moderate, and severe novel coronavirus pneumonia. As a botanical combination, its mechanism of action is likely pleiotropic, involving immunomodulation and anti-inflammatory pathways to mitigate the symptoms of viral pneumonia. The formula was part of a broader effort in China to integrate TCM into the emergency response to the SARS-CoV-2 pandemic.

Other names
新冠1号Xin-Guan-1 decoctionXin-Guan1 decoctionXin-Guan 1 decoction
02

Targets

IL-6R (Interleukin-6 receptor subunit alpha)Spike-ACE2 PPI (SARS-CoV-2 spike–ACE2 interface)Mpro (3C-like proteinase of SARS-CoV-2)

Beyond the preview

Go deeper on Xin-Guan-1 formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xin-Guan-1 formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call